Windtree Enters into Agreement with Lee's Pharmaceutical for Non-Dilutive Funding of the Continued Development of AEROSURF®
Round Type
Grant
WarringtonBiotechnologyHealth CareTherapeuticsPharmaceuticalDescription
Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, announces it has entered into a binding term sheet (the "Term Sheet") with Lee's Pharmaceutical Holdings (HK) Ltd ("Lee's") pursuant to which Lee's will provide project financing for the continued development of the Company's lead acute pulmonary product candidate, AEROSURF® for the treatment of preterm infants with respiratory distress syndrome ("RDS"). The financing will fund the AEROSURF phase 2b bridge study which, if successful, is intended to transition the product into a phase 3 ready clinical product development.
Quick answer
Windtree Therapeutics raised an undisclosed amount in a Grant round, dated March 31, 2020. Windtree Therapeutics is based in Warrington, Pennsylvania, United States.
- How much did Windtree Therapeutics raise?
- Windtree Therapeutics raised an undisclosed amount in a Grant round on March 31, 2020.
- What does Windtree Therapeutics do?
- Windtree Therapeutics, Inc. is a pharmaceutical company focused on developing novel therapeutics for the treatment of a broad range of diseases.
- Where is Windtree Therapeutics based and how big is it?
- Windtree Therapeutics is based in Warrington, Pennsylvania, United States.
- Who are the decision-makers at Windtree Therapeutics?
- Fundz holds 1 contact at Windtree Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Windtree Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Lisata Therapeutics raised $2.4M (Seed) on May 12, 2020.
- Oragenics raised $4.6M (Seed) on May 6, 2020.
- Os Therapies raised an undisclosed amount on May 1, 2020.
- Olema Pharmaceuticals, Inc. raised $30M on March 27, 2020.
- Nurix Therapeutics raised $120M on March 26, 2020.
- Ocugen raised $14M on May 7, 2020.
Who to call at Windtree Therapeutics, and when
A new round usually means Windtree Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Windtree Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Windtree Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Windtree Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Windtree Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Windtree Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.